Which three-dimensional characteristics make efficient inhibitors of protein–protein interactions?

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · see citing works

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · see citing works

The influence of drug-like concepts on decision-making in medicinal chemistry

Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · see citing works

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,145 · see citing works

Molecular Descriptors for Chemoinformatics

Todeschini, R., & Consonni, V. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527628766 · Cited by 1,881 · see citing works

The role of ligand efficiency metrics in drug discovery

Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181 · see citing works

The PDBbind Database: Collection of Binding Affinities for Protein−Ligand Complexes with Known Three-Dimensional Structures

Wang, R., Fang, X., Lu, Y., & Wang, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030580l · Cited by 1,137 · see citing works

The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?

Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 913 · see citing works

Constructing Confidence Sets Using Rank Statistics

Bauer, D. (1972) · Journal of the American Statistical Association · doi:10.1080/01621459.1972.10481279 · Cited by 812 · see citing works

Probing the links between in vitro potency, ADMET and physicochemical parameters

Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. P. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3367 · Cited by 514 · see citing works

VolSurf: a new tool for the pharmacokinetic optimization of lead compounds

Cruciani, G., Pastor, M., & Guba, W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00162-7 · Cited by 429 · see citing works

Molecular obesity, potency and other addictions in drug discovery

Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 367 · see citing works

Predicting druggable binding sites at the protein–protein interface

Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.009 · Cited by 311 · see citing works

Frog2: Efficient 3D conformation ensemble generator for small compounds

Miteva, M. A., Guyon, F., & Tufféry, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq325 · Cited by 288 · see citing works

Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery

Pérot, S., Spérandio, O., Miteva, M. A., Camproux, A., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.015 · Cited by 277 · see citing works

PrePPI: a structure-informed database of protein–protein interactions

Zhang, Q. C., Petrey, D. S., Garzón, J. I., Deng, L., & Honig, B. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1231 · Cited by 239 · see citing works

Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)

Morelli, X., Bourgeas, R., & Roche, P. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.024 · Cited by 223 · see citing works

Rationalizing the chemical space of protein–protein interaction inhibitors

Spérandio, O., Reynès, C., Camproux, A., & Villoutreix, B. O. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.11.007 · Cited by 202 · see citing works

DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein–protein interactions

ger, D. M. K. ⁄., & Gohlke, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq471 · Cited by 169 · see citing works

Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds

Petitjean, M. (1992) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00008a012 · Cited by 166 · see citing works

Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.

Li, H., Xiao, H., Lin, L., Jou, D., Kumari, V., Lin, J., & Li, C.-L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401144z · Cited by 155 · see citing works

2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions

Basse, M. J., Betzi, S., Bourgeas, R., Bouzidi, S., Chetrit, B., Hamon, V., Morelli, X., & Roche, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1002 · Cited by 148 · see citing works

e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design

Pihan, É., Colliandre, L., Guichou, J., & Douguet, D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts186 · Cited by 143 · see citing works

Drugs Targeting Protein–Protein Interactions

Chêne, P. (2006) · ChemMedChem · doi:10.1002/cmdc.200600004 · Cited by 129 · see citing works

The importance of discerning shape in molecular pharmacology

Kortagere, S., Krasowski, M. D., & Ekins, S. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.001 · Cited by 124 · see citing works

Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods

Reynès, C., Host, H., Camproux, A., Laconde, G., Leroux, F., Mazars, A., Deprez, B. P., Fåhræus, R., Villoutreix, B. O., & Spérandio, O. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000695 · Cited by 119 · see citing works

iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein–protein interactions

Labbé, C. M., Laconde, G., Kuenemann, M. A., Villoutreix, B. O., & Sperandio, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.003 · Cited by 104 · see citing works

On the analytical calculation of van der Waals surfaces and volumes: Some numerical aspects

Petitjean, M. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150504 · Cited by 104 · see citing works

TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions

Higueruelo, A. P., Jubb, H., & Blundell, T. L. (2013) · Database · doi:10.1093/database/bat039 · Cited by 93 · see citing works

Drug-Like Inhibitors of Protein-Protein Interactions: A Structural Examination of Effective Protein Mimicry

Fry, D. C. (2008) · Current Protein and Peptide Science · doi:10.2174/138920308784533989 · Cited by 76 · see citing works

Prediction of Protein−Protein Interaction Inhibitors by Chemoinformatics and Machine Learning Methods

Neugebauer, A., Hartmann, R. W., & Klein, C. D. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070533j · Cited by 75 · see citing works

Using CONCORD to construct a large database of three-dimensional coordinates from connection tables

Rusinko, A., Sheridan, R. P., Nilakantan, R., Haraki, K. S., Bauman, N., & Venkataraghavan, R. (1989) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00064a004 · Cited by 73 · see citing works

Molecular Shape Profiles

Randić, M. (1995) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00025a005 · Cited by 68 · see citing works

A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors

Villoutreix, B. O., Labbé, C. M., Lagorce, D., Laconde, G., & Spérandio, O. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651571 · Cited by 68 · see citing works

Sample size calculation for the Wilcoxon–Mann–Whitney test adjusting for ties

Zhao, Y. D., Rahardja, D., & Qu, Y. (2007) · Statistics in Medicine · doi:10.1002/sim.2912 · Cited by 67 · see citing works

Surface Descriptors for Protein−Ligand Affinity Prediction

Zamora, I., Oprea, T. I., Cruciani, G., Pastor, M., & Ungell, A.-L. B. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011051p · Cited by 60 · see citing works

Blind prediction of interfacial water positions in CAPRI

Lensink, M. F., Moal, I. H., Bates, P. A., Kastritis, P. L., Melquiond, A. S. J., Karaca, E., Schmitz, C., van Dijk, M., Bonvin, A. M. J. J., Eisenstein, M., et al. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24439 · Cited by 54 · see citing works

Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities

Huang, Y., Wolf, S., Beck, B., Köhler, L.-M., Khoury, K., Popowicz, G. M., Goda, S. K., Subklewe, M. S., Twarda‐Clapa, A., Holak, T. A., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb400728e · Cited by 42 · see citing works

Learning lessons from drugs that have recently entered the market

Teague, S. J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.003 · Cited by 38 · see citing works

Bioactive Molecules: Perfectly Shaped for Their Target?

Wirth, M., & Sauer, W. (2011) · Molecular Informatics · doi:10.1002/minf.201100034 · Cited by 25 · see citing works

Topography-biased compound library design: the shape of things to come?

Akritopoulou‐Zanze, I., Metz, J. T., & Djurić, S. W. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.017 · Cited by 19 · see citing works

Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges

Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01089 · Cited by 331 · see citing works

Targeting intrinsically disordered proteins at the edge of chaos

Ruan, H., Sun, Q., Zhang, W., Liu, Y., & Lai, L. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.017 · Cited by 133 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

A Combined Experimental and Computational Strategy to Define Protein Interaction Networks for Peptide Recognition Modules

Tong, A. H. Y., Drees, B., Nardelli, G., Bader, G. D., Brannetti, B., Castagnoli, L., Evangelista, M., Ferracuti, S., Nelson, B., Paoluzi, S., et al. (2002) · Science · doi:10.1126/science.1064987 · Cited by 692 · see citing works

Bacterial protein interaction networks: puzzle stones from solved complex structures add to a clearer picture

Terradot, L., & Noirot‐Gros, M. (2011) · Integrative Biology · doi:10.1039/c0ib00023j · Cited by 5 · see citing works

Detection of Peptides, Proteins, and Drugs That Selectively Interact With Protein TargetsPreprint

Serebriiskii, I. G., Mitina, O., Pugacheva, E. N., Benevolenskaya, E. V., Kotova, E., Toby, G. G., Khazak, V., Kaelin, W. G., Chernoff, J., & Golemis, E. A. (2002) · Genome Research · doi:10.1101/gr.450702 · Cited by 39 · see citing works

High-throughput methods for identification of protein-protein interactions involving short linear motifs

Blikstad, C., & Ivarsson, Y. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0116-8 · Cited by 58 · see citing works